|
Jul 28
|
Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
|
|
Dec 1
|
Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million
|
|
Nov 28
|
U.S. Stocks Open Mostly Lower, With S&P 500 Falling Slightly Ahead Of Fed Speakers
|
|
Aug 9
|
Q2 2023 Fate Therapeutics Inc Earnings Call
|